NCT04705922View on ClinicalTrials.gov

Relative Bioavailability Study and Food Effect Study of TT-00420 (Tinengotinib) Capsule and Tablet Formulations in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 29, 2020

Primary Completion Date

March 7, 2021

Study Completion Date

July 23, 2021

Conditions
Healthy
Interventions
DRUG

TT-00420 Capsule

TT-00420 capsule formulation, administered orally

DRUG

TT-00420 Tablet

TT-00420 tablet formulation, administered orally

Trial Locations (1)

21201

Pharmaron CPC, Baltimore

All Listed Sponsors
lead

TransThera Sciences (Nanjing), Inc.

INDUSTRY

NCT04705922 - Relative Bioavailability Study and Food Effect Study of TT-00420 (Tinengotinib) Capsule and Tablet Formulations in Healthy Volunteers | Biotech Hunter | Biotech Hunter